Cargando…
Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
BACKGROUND: Huntington’s disease (HD) is a multifaceted neurodegenerative disorder characterized by involuntary movements, specifically chorea, as well as behavioral and psychiatric disturbance, and cognitive dysfunction. Tetrabenazine was the first approved treatment for chorea, although tolerabili...
Autores principales: | Sung, Victor W., Iyer, Ravi G., Gandhi, Sanjay K., Abler, Victor, Davis, Brian, Irwin, Debra E., Anderson, Karen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309957/ https://www.ncbi.nlm.nih.gov/pubmed/32685569 http://dx.doi.org/10.36469/9779 |
Ejemplares similares
-
Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease
por: Claassen, Daniel O., et al.
Publicado: (2021) -
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010) -
Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007) -
Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States
por: Thorley, Eileen Mack, et al.
Publicado: (2018) -
Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
por: Frank, Samuel
Publicado: (2011)